In September 2008, GE, a 78 year old male surgical oncologist who was otherwise in good health, had a stroke. The MRI/MRA revealed an acute infarct involving the right lentiform nucleus, moderately extensive chronic small vessel ischemic changes, chronic lacunar infarct involving the right ventromedial thalamus, and intracranial atherosclerotic vascular disease.

The stroke left GE with aphasia and a reduced ability to perform any physical activity.

October 2009, 13 months after the stroke, GE began taking SE; GE consumed 1 gram twice Tissue Regeneration – From Basic Biology to Clinical Application 186 per day and after 8 weeks on the product GE noticed improvement with his speech and experienced more energy with improved balance.

In April 2010 a repeat MRI/MRA showed no evidence of an acute infarct. GE’s aphasia was completely resolved at this point and his overall mobility was improved allowing him to perform all activities of daily living.

In January of 2011 a repeat MRI/MRA of the anterior and posterior cerebral arteries demonstrated no evidence of hemodynamically significant stenosis, and revealed normal vertebrobasilar arteries with no evidence of intracranial aneurysm or vascular malformation.

To date, GE has resumed playing tennis at age 81, walks around the mall in the neighbourhood with other senior citizens and has returned to his professional activity as a surgeon.

Christian Drapeau, a member of Gitte Jensen, Ph.D, research team that created the patented Stem Enhance ULTRA